Drug Type Small molecule drug |
Synonyms Cerivastatin, Cerivastatin sodium (JAN/USAN), Certa + [16] |
Target |
Action inhibitors |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (26 Jun 1997), |
Regulation- |
Molecular FormulaC26H34FNNaO5 |
InChIKeyUVXVKMCFVDNBCD-QCVDVZFFSA-N |
CAS Registry143201-11-0 |
Start Date01 Jul 2025 |
Sponsor / Collaborator |
Start Date29 Apr 2025 |
Sponsor / Collaborator- |
Start Date15 Mar 2025 |
Sponsor / Collaborator- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00889 | Cerivastatin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dyslipidemias | United States | 26 Jun 1997 | |
Hypercholesterolemia | United States | 26 Jun 1997 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | 45 | cfgdpvohih(ondhaqxqsj) = lspakkfuxr rtbrdpraej (sembbdiyax, 6.39) View more | Positive | 10 Nov 2008 |